JP2015535231A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015535231A5 JP2015535231A5 JP2015538458A JP2015538458A JP2015535231A5 JP 2015535231 A5 JP2015535231 A5 JP 2015535231A5 JP 2015538458 A JP2015538458 A JP 2015538458A JP 2015538458 A JP2015538458 A JP 2015538458A JP 2015535231 A5 JP2015535231 A5 JP 2015535231A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- alkyl
- compound according
- fluoro
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 26
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 21
- 125000001072 heteroaryl group Chemical group 0.000 claims 13
- 229910052736 halogen Inorganic materials 0.000 claims 10
- 125000001424 substituent group Chemical group 0.000 claims 9
- 125000005843 halogen group Chemical group 0.000 claims 8
- 150000002367 halogens Chemical class 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 238000006467 substitution reaction Methods 0.000 claims 8
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000001153 fluoro group Chemical group F* 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 125000004076 pyridyl group Chemical group 0.000 claims 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- OAZDBSGPAMIQCO-NRFANRHFSA-N 2-[(4s)-4-(2-fluorophenyl)-5,5-bis(4-fluorophenyl)-2-oxo-1,3-oxazolidin-3-yl]acetamide Chemical compound C1([C@@H]2N(C(OC2(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)=O)CC(=O)N)=CC=CC=C1F OAZDBSGPAMIQCO-NRFANRHFSA-N 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 2
- 206010048962 Brain oedema Diseases 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 2
- 206010038389 Renal cancer Diseases 0.000 claims 2
- 206010052779 Transplant rejections Diseases 0.000 claims 2
- 208000006673 asthma Diseases 0.000 claims 2
- 208000006752 brain edema Diseases 0.000 claims 2
- 201000010982 kidney cancer Diseases 0.000 claims 2
- 208000030761 polycystic kidney disease Diseases 0.000 claims 2
- 201000002793 renal fibrosis Diseases 0.000 claims 2
- 208000037803 restenosis Diseases 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 claims 1
- CWMDJCGLICPBMZ-NRFANRHFSA-N 2-[(4s)-4,5,5-tris(2-fluorophenyl)-2-oxo-1,3-oxazolidin-3-yl]acetamide Chemical compound C1([C@@H]2N(C(OC2(C=2C(=CC=CC=2)F)C=2C(=CC=CC=2)F)=O)CC(=O)N)=CC=CC=C1F CWMDJCGLICPBMZ-NRFANRHFSA-N 0.000 claims 1
- XWNOUAOTNUVPPW-NRFANRHFSA-N 2-[(4s)-4,5,5-tris(4-fluorophenyl)-2-oxo-1,3-oxazolidin-3-yl]acetamide Chemical compound C1([C@@H]2N(C(OC2(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)=O)CC(=O)N)=CC=C(F)C=C1 XWNOUAOTNUVPPW-NRFANRHFSA-N 0.000 claims 1
- DZWYJTVGTZAQIB-NRFANRHFSA-N 2-[(4s)-4-(2,4-difluorophenyl)-5,5-bis(4-fluorophenyl)-2-oxo-1,3-oxazolidin-3-yl]acetamide Chemical compound C1([C@@H]2N(C(OC2(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)=O)CC(=O)N)=CC=C(F)C=C1F DZWYJTVGTZAQIB-NRFANRHFSA-N 0.000 claims 1
- DMUBQSIUQZPUTR-NRFANRHFSA-N 2-[(4s)-4-(2-chlorophenyl)-5,5-bis(4-fluorophenyl)-2-oxo-1,3-oxazolidin-3-yl]acetamide Chemical compound C1([C@@H]2N(C(OC2(C=2C=CC(F)=CC=2)C=2C=CC(F)=CC=2)=O)CC(=O)N)=CC=CC=C1Cl DMUBQSIUQZPUTR-NRFANRHFSA-N 0.000 claims 1
- GHKLSGPVDKKCLL-NRFANRHFSA-N 2-[(4s)-4-(2-fluorophenyl)-2-oxo-5,5-diphenyl-1,3-oxazolidin-3-yl]acetamide Chemical compound C1([C@@H]2N(C(OC2(C=2C=CC=CC=2)C=2C=CC=CC=2)=O)CC(=O)N)=CC=CC=C1F GHKLSGPVDKKCLL-NRFANRHFSA-N 0.000 claims 1
- XEOTZKNFJQMQRR-NRFANRHFSA-N 2-[(4s)-4-(2-fluorophenyl)-5,5-bis(3-fluorophenyl)-2-oxo-1,3-oxazolidin-3-yl]acetamide Chemical compound C1([C@@H]2N(C(OC2(C=2C=C(F)C=CC=2)C=2C=C(F)C=CC=2)=O)CC(=O)N)=CC=CC=C1F XEOTZKNFJQMQRR-NRFANRHFSA-N 0.000 claims 1
- 208000026292 Cystic Kidney disease Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12190319 | 2012-10-29 | ||
| EP12190319.9 | 2012-10-29 | ||
| PCT/EP2013/072361 WO2014067861A1 (en) | 2012-10-29 | 2013-10-25 | 3,4-disubstituted oxazolidinone derivatives and their use as inhibitors of the calcium activated potassium channel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015535231A JP2015535231A (ja) | 2015-12-10 |
| JP2015535231A5 true JP2015535231A5 (enExample) | 2016-12-08 |
| JP6216385B2 JP6216385B2 (ja) | 2017-10-18 |
Family
ID=47143594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015538458A Expired - Fee Related JP6216385B2 (ja) | 2012-10-29 | 2013-10-25 | ３，４−二置換オキサゾリジノン誘導体及びカルシウム活性化カリウムチャネルの阻害薬としてのそれらの使用 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9611232B2 (enExample) |
| EP (1) | EP2912034B1 (enExample) |
| JP (1) | JP6216385B2 (enExample) |
| KR (1) | KR20150075091A (enExample) |
| CN (1) | CN104781256B (enExample) |
| AR (1) | AR093168A1 (enExample) |
| AU (1) | AU2013339607A1 (enExample) |
| BR (1) | BR112015003996A2 (enExample) |
| CA (1) | CA2879249A1 (enExample) |
| CL (1) | CL2015000906A1 (enExample) |
| CO (1) | CO7170170A2 (enExample) |
| CR (1) | CR20150159A (enExample) |
| EA (1) | EA026161B1 (enExample) |
| IL (1) | IL237331A0 (enExample) |
| IN (1) | IN2015DN00961A (enExample) |
| MA (1) | MA38135B1 (enExample) |
| MX (1) | MX2015002399A (enExample) |
| PE (1) | PE20150775A1 (enExample) |
| PH (1) | PH12015500292A1 (enExample) |
| SG (1) | SG11201500585XA (enExample) |
| TW (1) | TW201422596A (enExample) |
| UA (1) | UA114649C2 (enExample) |
| WO (1) | WO2014067861A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102047502B1 (ko) * | 2016-06-20 | 2019-11-22 | 셀라이온바이오메드 주식회사 | 포타슘 채널 단백질을 이용한 암 진단용 조성물 |
| PE20220261A1 (es) | 2019-03-22 | 2022-02-22 | Saniona As | Inhibidores del canal de potasio novedosos |
| MX2023003306A (es) | 2020-09-22 | 2023-06-06 | Saniona As | Inhibidores del canal de potasio novedosos. |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2538424C2 (de) * | 1975-08-29 | 1983-01-05 | Nordmark-Werke Gmbh, 2000 Hamburg | 4-substituierte 5-Phenyl-oxazolidon-(2)- Verbindungen und ein diese enthaltendes pharmazeutisches Präparat |
| EP0215435B1 (en) * | 1985-09-09 | 1993-03-03 | Otsuka Pharmaceutical Co., Ltd. | 2-oxa-isocephem compounds, compositions containing same and processes for preparing same |
| KR930703262A (ko) * | 1990-11-06 | 1993-11-29 | 스튜어트 알. 슈터 | 이미다졸리디논 화합물 |
| DE4439846A1 (de) * | 1994-11-08 | 1996-05-09 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
| WO1997031892A1 (fr) * | 1996-03-01 | 1997-09-04 | Sankyo Company, Limited | Derives d'acide hydroxamique |
| JP2002531552A (ja) * | 1998-12-04 | 2002-09-24 | ニューロサーチ、アクティーゼルスカブ | イオンチャネル調節剤としての新規ベンズイミダゾロン−、ベンズオキサゾロン−又はベンゾチアゾロン−誘導体 |
| HUP0204071A3 (en) * | 2000-01-20 | 2003-07-28 | Eisai Co Ltd | Nitrogenous cyclic compounds and pharmaceutical compositions containing the same and their use |
| JP3966693B2 (ja) * | 2000-01-20 | 2007-08-29 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 含窒素環化合物およびそれらを含んでなる医薬組成物 |
| WO2002042299A1 (de) * | 2000-11-22 | 2002-05-30 | Bayer Aktiengesellschaft | Neue lactam-substituierte pyrazolopyridinderivate |
| WO2006015159A2 (en) | 2004-07-29 | 2006-02-09 | Merck & Co., Inc. | Potassium channel inhibitors |
| DE102004060229A1 (de) * | 2004-12-15 | 2006-06-29 | Sanofi-Aventis Deutschland Gmbh | Neue zyklische Harnstoffe als Inhibitoren von Metallproteasen |
| US7378530B2 (en) * | 2005-02-22 | 2008-05-27 | Nereus Pharmaceuticals, Inc. | Anti-cancer and anti-microbial 5-membered heterocyclic compounds |
| US20100056637A1 (en) | 2005-12-20 | 2010-03-04 | Icagen, Inc. | Treatment methods using triaryl methane compounds |
| WO2007109098A2 (en) * | 2006-03-16 | 2007-09-27 | Azevan Pharmaceuticals, Inc. | HYDROXY AND KETO-SUBSTITUTED β-LACTAMYL ALKANEDIOIC ACIDS |
| AR074558A1 (es) * | 2008-12-12 | 2011-01-26 | Solvay Pharm Bv | Espiro azepan oxazolidinonas como bloqueadores del canal de potasio kv1.3 |
| WO2010123997A1 (en) * | 2009-04-22 | 2010-10-28 | Achaogen, Inc. | Carbacephem beta-lactam antibiotics |
-
2013
- 2013-10-25 SG SG11201500585XA patent/SG11201500585XA/en unknown
- 2013-10-25 KR KR1020157011024A patent/KR20150075091A/ko not_active Withdrawn
- 2013-10-25 MX MX2015002399A patent/MX2015002399A/es unknown
- 2013-10-25 JP JP2015538458A patent/JP6216385B2/ja not_active Expired - Fee Related
- 2013-10-25 WO PCT/EP2013/072361 patent/WO2014067861A1/en not_active Ceased
- 2013-10-25 PE PE2015000296A patent/PE20150775A1/es not_active Application Discontinuation
- 2013-10-25 BR BR112015003996A patent/BR112015003996A2/pt not_active IP Right Cessation
- 2013-10-25 UA UAA201504977A patent/UA114649C2/uk unknown
- 2013-10-25 EP EP13783333.1A patent/EP2912034B1/en not_active Not-in-force
- 2013-10-25 EA EA201590729A patent/EA026161B1/ru not_active IP Right Cessation
- 2013-10-25 MA MA38135A patent/MA38135B1/fr unknown
- 2013-10-25 AU AU2013339607A patent/AU2013339607A1/en not_active Abandoned
- 2013-10-25 IN IN961DEN2015 patent/IN2015DN00961A/en unknown
- 2013-10-25 CN CN201380056503.4A patent/CN104781256B/zh not_active Expired - Fee Related
- 2013-10-25 CA CA2879249A patent/CA2879249A1/en not_active Abandoned
- 2013-10-28 TW TW102138950A patent/TW201422596A/zh unknown
- 2013-10-28 AR ARP130103922A patent/AR093168A1/es unknown
-
2015
- 2015-01-16 CO CO15008510A patent/CO7170170A2/es unknown
- 2015-02-10 PH PH12015500292A patent/PH12015500292A1/en unknown
- 2015-02-19 IL IL237331A patent/IL237331A0/en unknown
- 2015-03-20 CR CR20150159A patent/CR20150159A/es unknown
- 2015-04-10 CL CL2015000906A patent/CL2015000906A1/es unknown
- 2015-04-29 US US14/699,144 patent/US9611232B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018519323A5 (enExample) | ||
| JP2015501327A5 (enExample) | ||
| HRP20240161T1 (hr) | Inhibitor atr i njegova primjena | |
| JP2014513110A5 (enExample) | ||
| JP2012111770A5 (enExample) | ||
| JP2015503609A5 (enExample) | ||
| JP2012532112A5 (enExample) | ||
| JP2016506962A5 (enExample) | ||
| JP2011519854A5 (enExample) | ||
| JP2013544860A5 (enExample) | ||
| RU2011147181A (ru) | Азетидинилдиамиды в качестве ингибиторов моноациглицерин-липазы | |
| HRP20171696T1 (hr) | 3,4-dihidroizokinolin-2(1h)-ilni spojevi | |
| JP2014530900A5 (enExample) | ||
| JP2014526500A5 (enExample) | ||
| HRP20210459T1 (hr) | Supstituirani derivati oksopiridina | |
| JP2013505969A5 (enExample) | ||
| JP2015531366A5 (enExample) | ||
| RU2015123499A (ru) | Соединения замещенной триазолбороновой кислоты | |
| JP2016514719A5 (enExample) | ||
| JP2017517508A5 (enExample) | ||
| JP2015537015A5 (enExample) | ||
| HRP20180060T1 (hr) | Kondenzirani arilni i heteroarilni laktami | |
| JP2016535772A5 (enExample) | ||
| JP2016501250A5 (enExample) | ||
| JP2016505614A5 (enExample) |